Atlas Trials

UMIT-1 Trial Favipiravir & Ribavirin for the Treatment of CCHF

Clinical trial NCT05940545 · UNKNOWN

Trial details

NCT number
NCT05940545
Sponsor
Liverpool School of Tropical Medicine
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
CCHF
Start date
2023-07-12
Primary completion
2023-09-30
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.